{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifjj73qojjizh6om7yrn5bc3pr7mt2uvgizqbwraqupfe7436u2ba",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3miayh6tu5xd2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaaali5dmgpxnlvtagb2c7mg5mfom62blpxpqrz3sl2qr4lpa5454"
    },
    "mimeType": "image/webp",
    "size": 98900
  },
  "path": "/2026/03/29/insilico-medicine-lilly-sign-ai-drug-commercialization-deal/?utm_campaign=rss",
  "publishedAt": "2026-03-29T18:06:50.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Health tech",
    "Pharma",
    "Artificial intelligence",
    "biotechnology",
    "drug development",
    "Eli Lilly",
    "STAT+"
  ],
  "textContent": "Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks",
  "title": "STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion",
  "updatedAt": "2026-03-29T18:10:24.000Z"
}